Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$560,677
-$622,059 QoQ
Shares Held
41,409
-79.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#183
of 625 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,677 | 41,409 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,182,736 | 197,452 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,393,431 | 194,342 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,282,720 | 213,738 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,204,889 | 227,778 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,363,136 | 427,343 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,050,476 | 405,528 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,516,228 | 236,081 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,300,154 | 207,737 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,425,555 | 235,402 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,575,278 | 247,939 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $16,544,929 | 953,049 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,228,769 | 924,016 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,741,980 | 924,404 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $23,424,497 | 838,686 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $22,750,812 | 972,257 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,020,336 | 1,008,010 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $34,920,811 | 999,737 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,125,140 | 923,650 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,268,113 | 374,142 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,778,108 | 554,465 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||